Organisation paid for research Program year 2025 Source: CMS Open Payments

Matrix Clinical Researchinc

Neither a doctor nor a teaching hospital

Research payments

$936,587

66 payments

Through program year 2025, Matrix Clinical Researchinc is reported as receiving $936,587 in research payments, across 66 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$233,047	13
2024	Research	$226,481	40
2023	Research	$471,158	12
2021	Research	$5,900	1

Breakdown

Who paid Research payments · program years 2021–2025

GlaxoSmithKline, LLC. $930,687 65 payments
Takeda Pharmaceuticals U.S.A., Inc. $5,900 1 payment

Studies the money was for Research payments · program years 2021–2025

A Phase II, Observer-Blind, Randomized, Controlled Study to Evaluate T $531,620 33 payments
A Phase II, Single-Blind, Randomized, Controlled Study to Evaluate the $200,343 24 payments
A Phase 3A, Observer-Blind, Randomized, Controlled Study to Evaluate T $181,724 6 payments
A Phase 3A, Open-Label, Randomized, Controlled Study to Evaluate the I $9,500 1 payment
Phase Iiib, Observer-Blind, Randomized, Placebo-Controlled, Multi-Cent $7,500 1 payment
EVA-25185: Gastroparesis Screener and EQ-5D Psychometric Study $5,900 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.